In males, obesity increases testicular ROS and inflammation, suppressing steroidogenic enzymes through NF-κB and lowering serum testosterone with compromised sperm quality [55]; in diabetes, NF-κB activation reduces transcripts required for testosterone synthesis, while anti-inflammatory/antioxidant interventions reverse these effects [56]. Here, NFKB1 is linked to diabetes mellitus.